EE+ POEM Archive
Genotype-guided selection of oral P2Y12 inhibitor therapy no better than standard therapy after PCI for ACS or stable CAD
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Genotype-guided Selection of Oral P2Y12 Inhibitor Therapy No Better Than Standard Therapy After PCI for ACS or Stable CAD." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315201/0/Genotype_guided_selection_of_oral_P2Y12_inhibitor_therapy_no_better_than_standard_therapy_after_PCI_for_ACS_or_stable_CAD.
Genotype-guided selection of oral P2Y12 inhibitor therapy no better than standard therapy after PCI for ACS or stable CAD. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315201/0/Genotype_guided_selection_of_oral_P2Y12_inhibitor_therapy_no_better_than_standard_therapy_after_PCI_for_ACS_or_stable_CAD. Accessed April 26, 2024.
Genotype-guided selection of oral P2Y12 inhibitor therapy no better than standard therapy after PCI for ACS or stable CAD. (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315201/0/Genotype_guided_selection_of_oral_P2Y12_inhibitor_therapy_no_better_than_standard_therapy_after_PCI_for_ACS_or_stable_CAD
Genotype-guided Selection of Oral P2Y12 Inhibitor Therapy No Better Than Standard Therapy After PCI for ACS or Stable CAD [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2024 April 26]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315201/0/Genotype_guided_selection_of_oral_P2Y12_inhibitor_therapy_no_better_than_standard_therapy_after_PCI_for_ACS_or_stable_CAD.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Genotype-guided selection of oral P2Y12 inhibitor therapy no better than standard therapy after PCI for ACS or stable CAD
ID - 1315201
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315201/0/Genotype_guided_selection_of_oral_P2Y12_inhibitor_therapy_no_better_than_standard_therapy_after_PCI_for_ACS_or_stable_CAD
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
